35.38 USD
▼-0.35-0.98%
盘后 35.26 -0.34%
2026-09-15
市值
$1.76B
市盈率
—
EPS
-0.59
股息率
—
52 周区间
9.32 – 57.14
成交量
135.73K
Beta
0.57
目标价
45.28
52W 低 9.3252W 高 57.14
价格走势
公司简介
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Th...